Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162850 · ClinicalTrials.gov registry record · NA
Oral Polypodium Leucotomos for Melasma
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT01162850 is a NA study that has completed, run by University of Miami. The registered enrollment target is 21 participants.
The verdict
NCT01162850, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Primary Objective: To determine whether there is improvement in the melasma of participants taking oral Polypodium Leucotomos Secondary Objective: To determine whether oral Polypodium Leucotomos is well tolerated in study subjects with melasma. To determine whether treatment with Polypodium Leucotomos improves the health-related quality of life.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Polypodium Leucotomos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162850
The ClinicalTrials.gov registry entry for NCT01162850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01162850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01162850 about?
NCT01162850 is a clinical study titled "Oral Polypodium Leucotomos for Melasma". Primary Objective: To determine whether there is improvement in the melasma of participants taking oral Polypodium Leucotomos Secondary Objective: To determine whether oral Polypodium Leucotomos is well tolerated in study subjects with melasma. To determine whether treatment with Polypodium Leucoto...
What is the current status of trial NCT01162850?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2008-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT01162850?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Polypodium Leucotomos (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01162850?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.